Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    June 2022
  1. RIEL H, MacPhee C, Rudolph ED, Tibbo PG, et al
    MMN and P3a elicited by a novelty paradigm in healthy controls: An investigation of sex differences.
    Neurosci Lett. 2022;781:136654.
    PubMed     Abstract available


    May 2022
  2. REN J, Chen Y, Fang X, Wang D, et al
    Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
    Neurosci Lett. 2022 May 23:136695. doi: 10.1016/j.neulet.2022.136695.
    PubMed     Abstract available


  3. ZHANG M, Hong X, Yang F, Fan H, et al
    Structural brain imaging abnormalities correlate with positive symptom in schizophrenia.
    Neurosci Lett. 2022 May 17:136683. doi: 10.1016/j.neulet.2022.136683.
    PubMed     Abstract available


    March 2022
  4. LI N, Huang J, Zhang P, Tong J, et al
    Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia.
    Neurosci Lett. 2022 Mar 22:136581. doi: 10.1016/j.neulet.2022.136581.
    PubMed     Abstract available


    February 2022
  5. CHENG P, Zhang R, Shan S, Yuan B, et al
    Novel IL1RAP mutation associated with schizophrenia interferes with neuronal growth and related NF-kappaB signal pathways.
    Neurosci Lett. 2022 Feb 15:136533. doi: 10.1016/j.neulet.2022.136533.
    PubMed     Abstract available


    December 2021
  6. SMUCNY J, Carter CS, Maddock RJ
    Magnetic resonance spectroscopic evidence of increased choline in the dorsolateral prefrontal and visual cortices in recent onset schizophrenia.
    Neurosci Lett. 2021;770:136410.
    PubMed     Abstract available


  7. YAN P, Gao B, Wang S, Wang S, et al
    Association of 5-HTR2A T102C and A-1438G polymorphisms with clinical response to atypical antipsychotic treatment in schizophrenia: A meta-analysis.
    Neurosci Lett. 2021;770:136395.
    PubMed     Abstract available


  8. LIU L, Hu Y, Lu Y, Hu L, et al
    Sex-dependent DNA hypermethylation of SLC6A4 in patients with schizophrenia.
    Neurosci Lett. 2021;769:136394.
    PubMed     Abstract available


    November 2021
  9. AZIMI SANAVI M, Ghazvini H, Ghalehnoei H, Zargari M, et al
    Effects of Clozapine and Risperidone Antipsychotic Drugs on the Expression of CACNA1C and Behavioral Changes in Rat 'Ketamine Model of Schizophrenia.
    Neurosci Lett. 2021 Nov 18:136354. doi: 10.1016/j.neulet.2021.136354.
    PubMed     Abstract available


    October 2021
  10. JUNG HY, Jung S, Bang M, Choi TK, et al
    White matter correlates of impulsivity in frontal lobe and their associations with treatment response in first-episode schizophrenia.
    Neurosci Lett. 2021 Oct 28:136309. doi: 10.1016/j.neulet.2021.136309.
    PubMed     Abstract available


    September 2021
  11. MOGHADDAM AH, Maboudi K, Bavaghar B, Sangdehi SRM, et al
    Neuroprotective effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like behaviors and oxidative damage in male mice.
    Neurosci Lett. 2021;765:136249.
    PubMed     Abstract available


  12. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available


    July 2021
  13. MAREDIA M, Hamilton J, Thanos PK
    A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain.
    Neurosci Lett. 2021;757:135976.
    PubMed     Abstract available


  14. VALES K, Holubova K
    Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: effect of treatment on cognitive functions.
    Neurosci Lett. 2021 Jul 2:136098. doi: 10.1016/j.neulet.2021.136098.
    PubMed     Abstract available


    June 2021
  15. RAMPINO A, Annese T, Torretta S, Tamma R, et al
    Involvement of Vascular Endothelial Growth Factor in schizophrenia.
    Neurosci Lett. 2021 Jun 30:136093. doi: 10.1016/j.neulet.2021.136093.
    PubMed     Abstract available


  16. ZHANG Q, He H, Cao B, Gao R, et al
    Analysis of cognitive impairment in schizophrenia based on machine learning: Interaction between psychological stress and immune system.
    Neurosci Lett. 2021;760:136084.
    PubMed     Abstract available


  17. SEILLIER A
    The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials.
    Neurosci Lett. 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.
    PubMed     Abstract available


  18. PATRIK S, Filip S
    Brain ventricular volume changes in schizophrenia. A narrative review.
    Neurosci Lett. 2021 Jun 16:136065. doi: 10.1016/j.neulet.2021.136065.
    PubMed     Abstract available


  19. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available


  20. KOLAR D, Kleteckova L, Brozka H, Vales K, et al
    Mini-Review: Brain Energy Metabolism and its Role in Animal Models of Depression, Bipolar Disorder, Schizophrenia and Autism.
    Neurosci Lett. 2021 Jun 4:136003. doi: 10.1016/j.neulet.2021.136003.
    PubMed     Abstract available


    April 2021
  21. MEIRON O, David J, Yaniv A
    Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia.
    Neurosci Lett. 2021;755:135912.
    PubMed     Abstract available


    January 2021
  22. GU S, Cui F, Yin J, Fang C, et al
    Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine.
    Neurosci Lett. 2021;746:135669.
    PubMed     Abstract available


  23. MATAS E, William Deakin JF, Toro CT
    Abnormal Expression of Post-Synaptic Proteins in Prefrontal Cortex of Patients with Schizophrenia.
    Neurosci Lett. 2021 Jan 10:135629. doi: 10.1016/j.neulet.2021.135629.
    PubMed     Abstract available


  24. CAI Y, Xing L, Yang T, Chai R, et al
    The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Neurosci Lett. 2021;741:135540.
    PubMed     Abstract available


    December 2020
  25. ABE K, Chiba Y, Katsuse O, Takahashi Y, et al
    Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis.
    Neurosci Lett. 2020;743:135588.
    PubMed     Abstract available


  26. ZHU L, Wu X, Xu B, Zhao Z, et al
    The Machine Learning Algorithm for the Diagnosis of Schizophrenia on the basis of Gene Expression in Peripheral Blood.
    Neurosci Lett. 2020 Dec 24:135596. doi: 10.1016/j.neulet.2020.135596.
    PubMed     Abstract available


  27. YU T, Li Y, Li N, Huang J, et al
    Abnormal functional connectivity of motor circuit in the schizophrenic patients with tardive dyskinesia: a resting-state fMRI study.
    Neurosci Lett. 2020 Dec 3:135548. doi: 10.1016/j.neulet.2020.135548.
    PubMed     Abstract available


    November 2020
  28. WATSON CJ, Thomas RH, Solomon T, Michael BD, et al
    COVID-19 and psychosis risk: real or delusional concern?
    Neurosci Lett. 2020 Nov 18:135491. doi: 10.1016/j.neulet.2020.135491.
    PubMed     Abstract available


    June 2020
  29. O'TUATHAIGH CMP, Desbonnet L, Payne C, Petit E 1st, et al
    Ethologically based behavioural and neurochemical characterisation of mice with isoform-specific loss of dysbindin-1A in the context of schizophrenia.
    Neurosci Lett. 2020 Jun 29:135218. doi: 10.1016/j.neulet.2020.135218.
    PubMed     Abstract available


  30. JUNG S, Kim JH, Sung G, Ko YG, et al
    Uncinate fasciculus white matter connectivity related to impaired social perception and cross-sectional and longitudinal symptoms in patients with schizophrenia spectrum psychosis.
    Neurosci Lett. 2020 Jun 10:135144. doi: 10.1016/j.neulet.2020.135144.
    PubMed     Abstract available


    May 2020
  31. FERREIRA FR, de Moura NSB, Camina LH, Pombo TR, et al
    Resveratrol ameliorates the effect of maternal immune activation associated with schizophrenia in adulthood offspring.
    Neurosci Lett. 2020 May 27:135100. doi: 10.1016/j.neulet.2020.135100.
    PubMed     Abstract available


  32. BANI-FATEMI A, Roy A, Dai N, Dada O, et al
    Genome-wide association study of aggression and violence in schizophrenia.
    Neurosci Lett. 2020 May 20:135061. doi: 10.1016/j.neulet.2020.135061.
    PubMed     Abstract available


  33. ZHUO C, Xu X, Lin X, Chen M, et al
    Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in China.
    Neurosci Lett. 2020 May 14:135033. doi: 10.1016/j.neulet.2020.135033.
    PubMed     Abstract available


    April 2020
  34. ZHAO Z, Xu G, Shen Z, Grunebaum M, et al
    The Effect of Auditory Verbal Hallucinations on the Relationship between Spontaneous Brain Activity and intraventricular Brain Temperature in Patients with Drug-Naive Schizophrenia.
    Neurosci Lett. 2020 Apr 20:134933. doi: 10.1016/j.neulet.2020.134933.
    PubMed     Abstract available


    February 2020
  35. CALABRO M, Porcelli S, Crisafulli C, Albani D, et al
    Genetic variants associated with psychotic symptoms across psychiatric disorders.
    Neurosci Lett. 2020;720:134754.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: